PHR लाइव सिग्नल्स | Getagraph.com के साथ लाभ को अधिकतम करें

Live Chart Being Loaded With Signals

Commentary (4 May 2024 @ 01:30):

Stats
आज की मात्रा	509 066
औसत मात्रा	493 787
बाजार मूल्य	1.26B
EPS	$0 ( 2024-03-27 )
अगली कमाई की तारीख	( $-0.510 ) 2024-05-29
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-8.89
ATR14	$0.0170 (0.08%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-01	Gunzburg Janet	Sell	286	Common Stock
2024-04-30	Goldstein Lainie	Buy	482	Common Stock
2024-04-30	Munson Gillian	Buy	482	Common Stock
2024-04-30	Cahill Edward L	Buy	482	Common Stock
2024-04-18	Gunzburg Janet	Sell	912	Common Stock

INSIDER POWER
-11.22
Last 98 transactions
Buy: 289 446 \| Sell: 357 726

मात्रा सहसंबंध

लंबा: -0.14 (neutral)

छोटा: -0.96 (very strong negative)

Signal:(31.417) Neutral

Phreesia Inc सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध

10 सबसे अधिक नकारात्मक सहसंबंध

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

Phreesia Inc सहसंबंध - मुद्रा/वस्त्र

0.27
( neutral )

0.07
( neutral )

0.00
( neutral )

-0.19
( neutral )

-0.53
( weak negative )

-0.25
( neutral )

Phreesia Inc वित्तीय

Annual	2024
राजस्व:	$356.30M
सकल लाभ:	$201.75M (56.62 %)
EPS:	$-2.51

FY	2024
राजस्व:	$356.30M
सकल लाभ:	$201.75M (56.62 %)
EPS:	$-2.51

FY	2023
राजस्व:	$280.91M
सकल लाभ:	$171.64M (61.10 %)
EPS:	$-3.36

FY	2022
राजस्व:	$213.23M
सकल लाभ:	$131.85M (61.83 %)
EPS:	$-2.37

Financial Reports:

No articles found.

Phreesia Inc

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, which are self-service intake tablets; and Arrivals Kiosks that are on-site kiosks. Its Phreesia Platform also provides a registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, and cost estimation tools; access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking; and life sciences solution to deliver targeted and clinically relevant marketing content to patients. In addition, the company's Phreesia Platform offers clinical support solution, which collects clinical intake and patient reported outcome (PRO) data for approximately 25 specialties, as well as enables healthcare services clients to communicate with their patients through surveys, announcements, text and email messaging, and health campaigns; and COVID-19 support modules for managing COVID-19 vaccine delivery and identify vaccine-hesitant patients, screening for self-reported COVID-19 risk factors, enabling contactless check-in during in-person visits, and collecting intake information during telehealth visits. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is headquartered in Raleigh, North Carolina.